You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

CLINICAL TRIALS PROFILE FOR DATSCAN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for DATSCAN

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00129181 ↗	Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease	Completed	GE Healthcare	N/A	2005-01-01	This study investigates whether there is a change in 123iodine-2ß- carbomethoxy-3ß-(4-iodophenyl) tropane ([123I]ß-CIT) uptake after short-term treatment with levodopa compared to either dopamine agonist or placebo.
NCT00129181 ↗	Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease	Completed	Pfizer	N/A	2005-01-01	This study investigates whether there is a change in 123iodine-2ß- carbomethoxy-3ß-(4-iodophenyl) tropane ([123I]ß-CIT) uptake after short-term treatment with levodopa compared to either dopamine agonist or placebo.
NCT00129181 ↗	Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease	Completed	Institute for Neurodegenerative Disorders	N/A	2005-01-01	This study investigates whether there is a change in 123iodine-2ß- carbomethoxy-3ß-(4-iodophenyl) tropane ([123I]ß-CIT) uptake after short-term treatment with levodopa compared to either dopamine agonist or placebo.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for DATSCAN

Condition Name

Chart
Table

Condition Name for DATSCAN
Intervention	Trials
Parkinson Disease	4
Parkinsonian Syndrome	2
REM Sleep Behavior Disorder	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for DATSCAN
Intervention	Trials
Parkinson Disease	8
Parkinsonian Disorders	4
Dementia	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for DATSCAN

Trials by Country

Map
Table

Trials by Country for DATSCAN
Location	Trials
United States	24
China	7
Germany	3
Spain	2
United Kingdom	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for DATSCAN
Location	Trials
Florida	3
Connecticut	3
Minnesota	2
California	2
Arizona	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for DATSCAN

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for DATSCAN
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	4
Phase 2	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for DATSCAN
Clinical Trial Phase	Trials
Completed	7
Enrolling by invitation	3
Recruiting	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DATSCAN

Sponsor Name

Chart
Table

Sponsor Name for DATSCAN
Sponsor	Trials
GE Healthcare	5
PPD	2
Institute for Neurodegenerative Disorders	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for DATSCAN
Sponsor	Trials
Other	24
Industry	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.